GALD vs NOVN: Side-by-Side Comparison
Compare Galderma Group N (GALD) and Novartis AG (NOVN) side by side: market cap CHF 43.03B vs CHF 244.54B, P/E 88.2 vs 22.7. Financials, growth and model signals on Bullrun.
| Metric | GALD | NOVN |
|---|---|---|
| Company | Galderma Group N | Novartis AG |
| Country / Exchange | Switzerland · SW | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - General |
| Market cap | CHF 43.03B | CHF 244.54B |
| P/E ratio | 88.2 | 22.7 |
| Dividend yield | 0.19% | 2.96% |
| Valuation model | — | 6.8% undervalued |
| Revenue (latest FY) | CHF 5.24B | — |
| Revenue growth YoY | +18.0% | — |
| Net income | CHF 613.00M | — |
| Gross margin | 68.9% | — |
| Diluted EPS | — | — |